NCT03209869 2022-09-13
Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2
University of Wisconsin, Madison
Phase 1 Withdrawn
Clinical Trials
8 trialsNCT01916187 2020-09-21
Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma
Canadian Cancer Trials Group
Phase 1 Withdrawn
NCT02557854 2019-03-19
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
University of Texas Southwestern Medical Center
Phase 1 Withdrawn
NCT00944580 2017-11-24
A Vaccine Study for High Risk Cancers
Penn State University
Phase 1 Withdrawn
NCT02745756 2017-08-30
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Withdrawn
NCT01130623 2017-07-02
A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn
NCT02439788 2017-06-14
GINAKIT
Baylor College of Medicine
Phase 1 Withdrawn
NCT01319838 2013-12-10
Aflac ST1001
Emory University
Phase 1 Withdrawn